Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Total PDS revenue $259,554,380

Total PDS revenue $259,554,380

posted on Aug 14, 2009 04:40PM

From the inception of the Commercialization Agreement to May 31, 2009, license revenues to PDS totaled $259,554,380.

Share
New Message
Please login to post a reply